Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

The Impact of Digital Health Solutions on Bridging the Health Care Gap in Rural Areas: A Scoping Review
Maita, Karla C. , Maniaci, Michael J. , Haider, Clifton R. , Lunde, Julianne J. , Torres-Guzman, Ricardo A, Coffey, Jordan D , Forte, Antonio Jorge , Maniaci, Michael J , Ávila, Francisco R. , Torres‐Guzman, Ricardo A. , Borna, Sahar , Coffey, Jordan , Demaerschalk, Bart M. , Forte, Antonio J.

The Permanente Journal | August 13, 2024 | Volume: 28 | Issue: 3 | Pages: 130-143

10.7812/tpp/23.134 | PMID 39135461 Get It

Prognostic Impacts of Age, Diagnosis Time, and Relapses in Primary CNS Lymphoma
Ohanyan, Sona , Stein, Polina , Ringelstein‐Harlev, Shimrit , Stein, Polina , Buxbaum, Chen , Shelly, Shahar

Journal of Clinical Medicine | August 13, 2024 | Volume: 13 | Issue: 16 | Pages: 4745

10.3390/jcm13164745 | PMID 39200887 Get It

Background: The incidence of lymphomatous involvement of the central nervous system (CNS) has been increasing in recent years. However, the rarity of the disease has resulted in a scarcity of available data regarding its clinical presentation, natural history, and prognosis. We aimed to investigate the neurological characteristics of uncommon lymphomatous involvements confined to the CNS and to identify key variables that could serve as predictive biomarkers for treatment outcomes. Methods: We identified patients presenting with neurological symptoms and diagnosed with CNS-restricted lymphomatous involvement between 2005 and 2023. Results: We identified 44 cases, 93% of which were diagnosed with primary central nervous system lymphoma (PCNSL) and 7% with intravascular lymphoma. The median time from symptom onset to diagnosis was 47 days (range: 6–573 days), with no statistically significant difference between patients older and younger than 60 years (p = 0.22). The median follow-up time was 1144 days (range: 27–3501 days). Cognitive deterioration was the most common presenting symptom, occurring in 19 out of 44 patients (43%). Brain MRI revealed that lobar lesions were the most frequent location of lesions, found in 24 out of 44 patients (55%). By the end of the study period, 30 patients (68%) had died, with a median survival of 666 days (range: 17–3291 days). Death was significantly more common in patients who experienced relapses (p = 0.04; 95% CI: 0.99–0.03), with these patients having a four times higher chance of death (HR = 4.1; 95% CI: 1.01–16.09). The time to diagnosis significantly correlated with survival (p = 0.02; 95% CI: 0.005–0.54), as did the Eastern Cooperative Oncology Group (ECOG) performance status at the last follow-up (p = 0.006; 95% CI: 0.0012–0.62). Patients aged over 60 years did not exhibit a higher likelihood of death (p = 0.19; HR = 2.3; 95% CI: 0.63–8.61); however, the threshold age at diagnosis for the maximally predicted mortality was 64 years (ROC = 0.73; p = 0.03). Conclusions: Patients had significant delays in diagnosis, affecting patient outcomes. Cognitive deterioration and lobar lesions were prominent clinical and radiological features. Mortality was notably higher in patients with relapses and those who had a longer time to diagnosis.
Evaluating the Timing Strategy and Permanence of Implementation of the OR-Stretch, An Intraoperative Ergonomic Microbreak for Surgeons
Anderson, Scott, Norasi, Hamid , Anderson, Scott, Hallbeck, M. Susan , Erben, Young

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | August 13, 2024 | Volume: 68 | Issue: 1 | Pages: 561-565

10.1177/10711813241261947 Get It

Ergonomic microbreaks such as the OR-Stretch can address work-related musculoskeletal pain among surgeons and potentially alleviate burnout and early retirement. Fifteen surgeons at a single institution completed two operative cases using the OR-Stretch, once using the Scheduled (every 45 min) timing strategy and once using the Self-Determined (between 30 and 60 min based on surgeon preference) strategy. Eight surgeons preferred the Scheduled timing strategy, and seven preferred Self-Determined ( p = .80). The stretch was skipped 16% of the time using the Scheduled strategy and 6% with the Self-Determined strategy ( p = .18). Personal interest, improved mental focus, and ease of remembering were cited as the most influential factors for continued usage, while the most influential factor for not continuing was forgetting to use it. Self-determined intervals for intraoperative microbreaks represent a valid and potentially preferable implementation approach. Efforts to promote long-term adoption of microbreaks should focus on reminding surgeons to use them during operations.
The Levator Veli Palatini: Are all Segments Created Equal?
Perry, Jamie L. , Snodgrass, Taylor D. , Gilbert, Imani , Chee-Williams, Jessica L. , Sitzman, Thomas J. , Gilbert, Imani R , Sitzman, Thomas J , Chee-Williams, Jessica L , Snodgrass, Taylor , Perry, Jamie L , Singh, Davinder

The Cleft Palate Craniofacial Journal | August 13, 2024 | Volume: 62 | Issue: 1 | Pages: 28-34

10.1177/10556656241271666 | PMID 39136069 Get It

Introduction The levator veli palatini (LVP) muscle has two segments with distinct roles in velopharyngeal function. Previous research suggests longer extravelar segments with shorter intravelar segments may lead to a more advantageous mechanism for velopharyngeal closure. The purpose of this study was to examine whether the distribution of the LVP intravelar and extravelar segments differs between children with cleft palate with and without VPI and controls. Methods The study included 97 children: 37 with cleft palate +/- lip with VPI, 37 controls, and 19 with cleft palate with normal resonance. Measures included mean LVP length, mean extravelar LVP length, and intravelar LVP length. Results Overall mean LVP length was similar ( P = .267) between controls and children with cleft palate (with and without VPI). However, there was a significant difference ( P < .001) between group for both intravelar and extravelar LVP lengths: the intravelar segment was significantly longer in those with VPI compared to controls and children with cleft palate and normal resonance; and the extravelar segment was significantly shorter in those with VPI compared to controls and children with cleft palate and normal resonance. Conclusions Results from this study demonstrate a significant difference between the distribution of the functional segments of the LVP among children with VPI, with a more disadvantageous distribution of the muscle segments among those with VPI.
The Alzheimer's Disease Neuroimaging Initiative Clinical Core
Aisen, Paul , Raman, Rema , Petersen, Ronald C., Initiative, for the Alzheimer's Disease Neuroimaging, Donohue, Michael , Rafii, Michael S. , Petersen, Ronald C. , Initiative, for the Alzheimer's Disease Neuroimaging

Alzheimer's & Dementia | August 13, 2024 | Volume: 20 | Issue: 10 | Pages: 7361-7368

10.1002/alz.14167 | PMID 39136045 Get It

Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical Core is responsible for coordination of all clinical activities at the ADNI sites, including project management, regulatory oversight, and site management and monitoring, as well as the collection of all clinical data and management of all study data. The Clinical Core is also charged with determining the clinical classifications and criteria for enrollment in evolving AD trials and enabling the ongoing characterization of the cross‐sectional features and longitudinal trajectories of the ADNI cohorts with application of these findings to optimal clinical trial designs. More than 2400 individuals have been enrolled in the cohorts since the inception of ADNI, facilitating refinement of our understanding of the AD trajectory and allowing academic and industry investigators to model therapeutic trials across the disease spectrum from the presymptomatic stage through dementia. Highlights Since 2004, the Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical Core has overseen the enrollment of > 2400 participants with mild cognitive impairment, mild Alzheimer's disease (AD) dementia, and normal cognition. The longitudinal dataset has elucidated the full cognitive and clinical trajectory of AD from its presymptomatic stage through the onset of dementia. The ADNI data have supported the design of most major trials in the field.
Spinal Gout: An Unusual Cause of Low Back Pain
Garrison, Gregory M. , Shu, Sara , Garrison, Gregory M

Journal of Primary Care & Community Health | August 13, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241271907 | PMID 39135504 Get It

Low back pain is the most common musculoskeletal complaint accounting for over 30 million visits to primary care physicians annually. Serious pathology is found in less than 1% of these visits. Therefore it is often a challenge to distinguish worrisome findings requiring further workup and treatment from common complaints of pain. Gout is an inflammatory arthritis that most commonly affects the appendicular skeleton. It is characterized by the saturation of uric acid and deposition of monosodium urate crystals in joints and tissues. Spinal involvement is rare and is not typically considered on the differential diagnosis for a patient presenting with acute low back pain. We present such a case of a 35-year-old male who presented with intractable back pain, highlighting the need to recognize signs and symptoms that raise suspicion for spinal gout.
Making the leap from idea generation to implementation: Ten steps every geriatrics specialist should know
Agarwal, Nimit , Pagali, Sandeep R. , Sharma, Kanishk D. , Walke, Lisa M., Pagali, Sandeep

Journal of the American Geriatrics Society | August 13, 2024 | Volume: 73 | Issue: 1 | Pages: 12-19

10.1111/jgs.19139 | PMID 39135348 Get It

Abstract This is an exciting time in Geriatrics, with numerous opportunities in health care for Geriatrics specialists to innovate and lead. Geriatrics specialists should know how to implement innovative care models to lead healthcare changes in their organizations and effectively facilitate change management. We highlight a 10‐step framework that Geriatrics specialists can leverage to quickly move their ideas from development to implementation at a system level. This framework adapts concepts from business management to provide a step‐by‐step guide to move from idea generation to implementation. We provide different practical examples that a Geriatrician can correlate to in their practice, including value proposition and business canvas model. Though small components of the business canvas model may vary based on organization and program/idea‐specific needs, the outlined skills will establish Geriatrics specialists as leaders of change, a resource for education, and valued consultants to a health system that is in dire need of direction to improve the quality of care, and health outcomes, for older adults.
Steering the multidisciplinary landscape of vascular medicine: Collaboration as the key to success for aspiring vascular medicine specialists
Cohoon, Kevin P. , Porres‐Aguilar, Mateo , Tomihama, Roger T. , Thomas, Sneha , Rogers, Everett M., Brunton, Nichole , Henkin, Stanislav , Hornacek, Deborah , Secemsky, Eric A. , Buckley, Anthony , Brunton, Nichole E , Henkin, Stanislav , Secemsky, Eric A , Porres-Aguilar, Mateo , Tomihama, Roger

Vascular Medicine | August 13, 2024 | Volume: 29 | Issue: 4 | Pages: 462-466

10.1177/1358863x241262723 | PMID 39135266 Get It

The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial
Tsaban, Gal , Aharon‐Hananel, Genya, Shalem, Shiran, Zelicha, Hila , Meir, Anat Yaskolka , Pachter, Dafna , Goldberg, D , Kamer, Omer , Alufer, Liav , Stampfer, Meir J. , Qi, Lu , Blüher, Matthias , Hu, Frank B., Shai, Iris , Qi, Lu , Blüher, Matthias , Yaskolka Meir, Anat , Shai, Iris , Goldberg, Dana Tamar , Wang, Dong D. , Stümvoll, Michael , Tirosh, Amir

Diabetes, Obesity and Metabolism | August 12, 2024 | Volume: 26 | Issue: 10 | Pages: 4713-4723

10.1111/dom.15840 | PMID 39134456 Get It

Abstract Aim To explore the effect of Mankai, a cultivated aquatic duckweed green plant, on postprandial glucose (PG) excursions in type 2 diabetes (T2D). Methods In a 4‐week, randomized crossover‐controlled trial, we enrolled 45 adults with T2D (HbA1c range: 6.5%‐8.5%) from two sites in Israel. Participants were randomized to drink Mankai (200 mL of raw‐fresh‐aquatic plant + 100 mL of water, 40 kcal, ~10 g of dry matter equivalent) or water (300 mL) following dinner, for 2 weeks each, with a 4‐day washout interval, without dietary, physical activity or pharmacotherapy alterations. We used continuous glucose monitoring (CGM) devices. Results Forty patients (adherence rate = 88.5%; 743 person‐intervention‐days, 68.9% men, age = 64 years, HbA1c = 6.8%) completed the study with a consistent diet and complete CGM reads. Only two‐thirds of the individuals responded beneficially to Mankai. Overall, Mankai significantly lowered the PG peak by 19.3% (∆peak = 24.3 ± 16.8 vs. 30.1 ± 18.5 mg/dL; P < .001) and delayed the time‐to‐peak by 20.0% (112.5 [interquartile range: 75‐135] vs. 90 [60‐105] min; P < .001) compared with water. The PG incline and decline slopes were shallower following postdinner Mankai (incline slope: 16.8 vs. water: 29.9 mg/[dL h]; P < .001; decline slope: −6.1 vs. water: −7.9 mg/[dL h]; P < .01). Mean postprandial net incremental area‐under‐the‐glucose‐curve was lowered by 20.1% with Mankai compared with water ( P = .03). Results were consistent across several sensitivity and subgroup analyses, including across antidiabetic pharmacotherapy treatment groups. Within 2 weeks, the triglycerides/high‐density lipoprotein cholesterol ratio in the Mankai group (−0.5 ± 1.3) decreased versus water (+0.3 ± 1.5, P = .05). Conclusions Mankai consumption may mitigate the PG response in people with T2D with an ~20% improvement in glycaemic values. These findings provide case‐study evidence for plant‐based treatments in T2D to complement a healthy lifestyle and pharmacotherapy.
Oculomotor Nerve Neuromyotonia
Irani, Sarosh R. , Oswal, Ashwini , Irani, Sarosh R , Handel, Adam E.

Neurology | August 12, 2024 | Volume: 103 | Issue: 5 | Pages: No page available

10.1212/wnl.0000000000209769 | PMID 39133881 Get It